A multicenter phase I trial of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814 in patients with solid tumors.

被引：6
|
作者：
van Bussel, Mark
Mau-Soerensen, Morten
Damstrup, Lars
Nielsen, Dorte
Verheul, Henk M. W.
Aftimos, Philippe Georges
De Jonge, Maja J.
Berghoff, Karin
Schellens, Jan H. M.
机构：
[1] Netherlands Canc Inst NKI, Amsterdam, Netherlands
[2] Rigshosp, Dept Oncol, Copenhagen, Denmark
[3] Merck KGaA, Darmstadt, Germany
[4] Herlev Hosp, Dept Oncol, Herlev, Denmark
[5] Canc Ctr, Dept Med Oncol, Amsterdam, Netherlands
[6] Inst Jules Bordet, Brussels, Belgium
[7] Erasmus MC, Canc Inst, Rotterdam, Netherlands
[8] Netherlands Canc Inst, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.2556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2556
引用
收藏
页数：5
相关论文
共 50 条
  • [1] A phase Ia/Ib trial of the DNA-dependent protein kinase inhibitor (DNA-PKi) M3814 in combination with radiotherapy in patients with advanced solid tumors.
    Van Triest, Baukelien
    Damstrup, Lars
    Falkenius, Johan
    Budach, Volker
    Troost, Esther
    Samuels, Michael
    Goddemeier, Thomas
    Geertsen, Poul F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Safety, clinical activity and pharmacological biomarker evaluation of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814: Results from two phase I trials
    Mau-Sorensen, M.
    van Bussel, M.
    Kuipers, M.
    Nielsen, D. L.
    Verheul, H. M.
    Aftimos, P.
    de Jonge, M. J. A.
    van Triest, B.
    Falkenius, J.
    Debus, J.
    Troost, E.
    Samuels, M.
    Sarholz, B.
    Budach, V.
    Goel, S.
    Locatelli, G.
    Geertsen, P. F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] DNA-PK inhibitor, M3814, as a radiation sensitizer in the treatment of neuroendocrine tumors
    Rychahou, Piotr
    Chauhan, Aman
    Chow, Zeta
    Izumi, Tadahidi
    Chen, Quan
    Lee, Eun Y.
    Napier, Dana
    Anthony, Lowell B.
    Cavnar, Michael J.
    Kunos, Charles
    Evers, B. Mark
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Utilising DNA-PK inhibitor, M3814, as a radiation sensitizer
    Fatima, A.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 40 - 40
  • [5] A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours
    Mark T. J. van Bussel
    Ahmad Awada
    Maja J. A. de Jonge
    Morten Mau-Sørensen
    Dorte Nielsen
    Patrick Schöffski
    Henk M. W. Verheul
    Barbara Sarholz
    Karin Berghoff
    Samer El Bawab
    Mirjam Kuipers
    Lars Damstrup
    Ivan Diaz-Padilla
    Jan H. M. Schellens
    British Journal of Cancer, 2021, 124 : 728 - 735
  • [6] A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours
    van Bussel, Mark T. J.
    Awada, Ahmad
    de Jonge, Maja J. A.
    Mau-Sorensen, Morten
    Nielsen, Dorte
    Schoffski, Patrick
    Verheul, Henk M. W.
    Sarholz, Barbara
    Berghoff, Karin
    El Bawab, Samer
    Kuipers, Mirjam
    Damstrup, Lars
    Diaz-Padilla, Ivan
    Schellens, Jan H. M.
    BRITISH JOURNAL OF CANCER, 2021, 124 (04) : 728 - 735
  • [7] Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models
    Zenke, Frank T.
    Zimmermann, Astrid
    Sirrenberg, Christian
    Dahmen, Heike
    Kirkin, Vladimir
    Pehl, Ulrich
    Grombacher, Thomas
    Wilm, Claudia
    Fuchss, Thomas
    Amendt, Christiane
    Vassilev, Lyubomir T.
    Blaukat, Andree
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (05) : 1091 - 1101
  • [8] M3814: A novel investigational DNA-PK inhibitor to target DNA double strand break repair
    Zenke, F. T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] A phase Ia/Ib trial of the DNA-PK inhibitor M3814 in combination with radiotherapy (RT) in patients (pts) with advanced solid tumors: Dose-escalation results.
    Van Triest, Baukelien
    Damstrup, Lars
    Falkenius, Johan
    Budach, Volker
    Troost, Esther
    Samuels, Michael
    Debus, Juergen
    Sorensen, Morten Mau
    Berghoff, Karin
    Strotman, Rainer
    van Bussel, Mark
    Goel, Sanjay
    Geertsen, Poul F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] M3814, a DNA-dependent Protein Kinase Inhibitor (DNA-PKi), Potentiates the Effect of Ionizing Radiation (IR) in Xenotransplanted Tumors in Nude Mice
    Damstrup, L.
    Zimmerman, A.
    Sirrenberg, C.
    Zenke, F.
    Vassilev, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 940 - 941
12345